Life Science Analytics Market size was valued at USD 26.80 Billion in 2022 and is poised to grow from USD 29.86 Billion in 2023 to USD 70.10 Billion by 2031, at a CAGR of 11.4 % during the forecast period (2024-2031).
In the last few years, the life science sector is rapidly adopting analytics and depends on descriptive and reporting analysis. These types of analysis are utilized for developing data bases and user prescriptive and predictive analysis for forecasting future trends and outcomes, contributing to the market growth. Another major factor positively influencing life science sector is the increasing impact of social media and internet. This directly effects the patient engagement and boosts the adoption of analytical solutions. Lately, medical facilities and life science companies are embracing analytical solutions to improve clinical, financial, and operational results. This also reduces medical expenses, augmenting the market growth. Life science organizations are readily implementing advanced analytics in their different operations like supply chain, R&D activities, clinical trial designing, regulatory compliance, sales & marketing, and pharmacovigilance. Life science companies and other medical sector stakeholders are also incorporating advanced data mining methods and big data analytics to precisely analyze the population at high risk strategize, driving the market growth. Nowadays, medical financing organizations and government facilities are applying predictive analytics in claims management and prevention of frauds, further progressing the market growth.
Download a detailed overview:
https://www.skyquestt.com/sample-request/life-science-analytics-market
Top Player’s Company Profiles
- Oracle (US)
- IBM (US)
- SAS Institute Inc. (US)
- Accenture (Ireland)
- IQVIA Inc (US)
- Cognizant (US)
- Wipro (India)
- Allscripts Healthcare, LLC (US)
- Optum, Inc. (US)
- Microsoft (US)
- MaxisIT (US)
- ExlService Holdings, Inc. (US)
- CitiusTech Inc (US)
- Saama Technologies, LLC. (US)
- Axtria (US)
- Clarivate (UK)
- ThoughtSphere (US)
- ThoughtSpot Inc. (US)
- Alteryx, Inc. (US)
- Sisense Inc. (US)
- Amazon Web Services, Inc. (US)
- Veeva Systems (US)
Development in Data Science and Adoption of Cloud Services to Enhance Decision-Making Process in Pharma & Biotech Companies
In recent times, the life science sector is going through massive transformations in clinical data management, medication discovery, and analytical capabilities. Benefits like improved speed & agility, enhanced customer insights, and better decision-making process have stimulated pharma & biotech organizations to make massive investments in innovative technologies to accelerate drug discovery procedures. Such benefits and the requirement to improve drug discovery procedure has increased the adoption of cloud infrastructures in the life science sector as they efficiently manage medical expenses and monitor growing prevalence of chronic diseases. The reduced cost related with cloud infrastructure, efficient way of controlling large data, and added benefits of strong security hugely responsible for this increasing adoption. Furthermore, the rising partnership among market players and research organizations for advancing innovative and efficient gene therapies utilizing cloud infrastructure are boosting the market growth.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/life-science-analytics-market
Segments covered
Type
Descriptive, Predictive, Prescriptive
Component
Software, Services
Delivery
On-Premise Model, On-Demand Model
Application
Research & Development (Preclinical Trials, Clinical Trials), Sales & Marketing, Regulatory Compliance, Supply Chain Optimization, Pharmacovigilance
End-User
Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Centers, Third-party Administrators
Increasing Usage Artificial Intelligence in Life Science to Manage Massive Volume of Data and Gather Useful Insights
The demand for AI is constantly increasing in the life science analytics market due to this explosion of data in the sector. With unparalleled volumes of clinical, medical, and biological data that are being generated from sources like genomics, proteomics, and electronic medical records, conventional process of analysis is proving to be useless. Artificial intelligence with the help of its advanced computational abilities has become a revolutionary solution in this field. Such advanced technologies can control and gathering useful insights from such huge and complex datasets. This massive amount of data provides immense opportunities for recognizing patterns, predicting diseases result, and improving various parts of medical and life science research. AI enables the incorporation and analysis of various type of data, offering researchers and medical professionals with the tools improve drug discovery. These factors are propelling the growth of life science analytics market.
- EPAM Systems acquired Odysseus Data Services in June 2024. The company extended its life science portfolio and ability to use advanced data analytics, AI, and ML with the help of this acquisition.
- Globa QMS was acquired by Clarivate Plc, in April 2024. This strategic move will improve Clarivate’s abilities in regulatory compliance and automation allowing life science companies to smoothen operations.
- Apollo Intelligence extended its market presence with the acquisition of GlocalMind in February 2024. This will improve Apollo’s access to healthcare professionals and key opinion leaders in Europe and Asia-Pacific.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/life-science-analytics-market
Increasing Investments in Advanced Analytics Solutions to Monitor Evolving Regulatory Settings and Boosts Safety
Recently the regulatory bodies have started implementing strict rules related to drug safety, efficiency, and quality standards. This have forced the life science organizations to invest in advanced analytics solutions to fulfil these standards. Analytics platforms helps organizations to track dangerous events, assess safety indications, and ensure obedience with evolving regulatory structures. Furthermore, analytics-based information helps in streamlining regulatory reporting procedure, minimize the risk of non-compliance penalties, and enables faster approvals of new drugs. The demand for comprehensive analytics solutions mainly arises from need to control complex regulatory settings efficiency. It also helps to maintain high standards of safety and compliance in life science sector.
Related Reports:
Visit Our Website: https://www.skyquestt.com/
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/life-science-analytics-market
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Life Science Analytics Market to Register CAGR of 11.4% by 2031: Driven by Increasing Adoption of Analytical Solutions to Improve Clinical Outcomes